In addition, reduction in tumor-induced immunosuppressive molecules such as TGF-β would increase the expression of NKG2D ligands on tumor cells, thereby improving the cytotoxic ability of NK cells and CD8+ T cells [32]. The gene discussed is TGFB1; the disease is neoplasm.